BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2896 related articles for article (PubMed ID: 29395269)

  • 1. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.
    Allemani C; Matsuda T; Di Carlo V; Harewood R; Matz M; Nikšić M; Bonaventure A; Valkov M; Johnson CJ; Estève J; Ogunbiyi OJ; Azevedo E Silva G; Chen WQ; Eser S; Engholm G; Stiller CA; Monnereau A; Woods RR; Visser O; Lim GH; Aitken J; Weir HK; Coleman MP;
    Lancet; 2018 Mar; 391(10125):1023-1075. PubMed ID: 29395269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).
    Allemani C; Weir HK; Carreira H; Harewood R; Spika D; Wang XS; Bannon F; Ahn JV; Johnson CJ; Bonaventure A; Marcos-Gragera R; Stiller C; Azevedo e Silva G; Chen WQ; Ogunbiyi OJ; Rachet B; Soeberg MJ; You H; Matsuda T; Bielska-Lasota M; Storm H; Tucker TC; Coleman MP;
    Lancet; 2015 Mar; 385(9972):977-1010. PubMed ID: 25467588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000-14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries.
    Ssenyonga N; Stiller C; Nakata K; Shalkow J; Redmond S; Bulliard JL; Girardi F; Fowler C; Marcos-Gragera R; Bonaventure A; Saint-Jacques N; Minicozzi P; De P; Rodríguez-Barranco M; Larønningen S; Di Carlo V; Mägi M; Valkov M; Seppä K; Wyn Huws D; Coleman MP; Allemani C;
    Lancet Child Adolesc Health; 2022 Jun; 6(6):409-431. PubMed ID: 35468327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Worldwide comparison of survival from childhood leukaemia for 1995-2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries.
    Bonaventure A; Harewood R; Stiller CA; Gatta G; Clavel J; Stefan DC; Carreira H; Spika D; Marcos-Gragera R; Peris-Bonet R; Piñeros M; Sant M; Kuehni CE; Murphy MFG; Coleman MP; Allemani C;
    Lancet Haematol; 2017 May; 4(5):e202-e217. PubMed ID: 28411119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer survival in five continents: a worldwide population-based study (CONCORD).
    Coleman MP; Quaresma M; Berrino F; Lutz JM; De Angelis R; Capocaccia R; Baili P; Rachet B; Gatta G; Hakulinen T; Micheli A; Sant M; Weir HK; Elwood JM; Tsukuma H; Koifman S; E Silva GA; Francisci S; Santaquilani M; Verdecchia A; Storm HH; Young JL;
    Lancet Oncol; 2008 Aug; 9(8):730-56. PubMed ID: 18639491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study.
    Arnold M; Rutherford MJ; Bardot A; Ferlay J; Andersson TM; Myklebust TÅ; Tervonen H; Thursfield V; Ransom D; Shack L; Woods RR; Turner D; Leonfellner S; Ryan S; Saint-Jacques N; De P; McClure C; Ramanakumar AV; Stuart-Panko H; Engholm G; Walsh PM; Jackson C; Vernon S; Morgan E; Gavin A; Morrison DS; Huws DW; Porter G; Butler J; Bryant H; Currow DC; Hiom S; Parkin DM; Sasieni P; Lambert PC; Møller B; Soerjomataram I; Bray F
    Lancet Oncol; 2019 Nov; 20(11):1493-1505. PubMed ID: 31521509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in cancer incidence in the Nordic countries. A collaborative study of the five Nordic Cancer Registries.
    Hakulinen T; Andersen A; Malker B; Pukkala E; Schou G; Tulinius H
    Acta Pathol Microbiol Immunol Scand Suppl; 1986; 288():1-151. PubMed ID: 3465196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data.
    Coleman MP; Forman D; Bryant H; Butler J; Rachet B; Maringe C; Nur U; Tracey E; Coory M; Hatcher J; McGahan CE; Turner D; Marrett L; Gjerstorff ML; Johannesen TB; Adolfsson J; Lambe M; Lawrence G; Meechan D; Morris EJ; Middleton R; Steward J; Richards MA;
    Lancet; 2011 Jan; 377(9760):127-38. PubMed ID: 21183212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer survival in Africa, central and south America, and Asia (SURVCAN-3): a population-based benchmarking study in 32 countries.
    Soerjomataram I; Cabasag C; Bardot A; Fidler-Benaoudia MM; Miranda-Filho A; Ferlay J; Parkin DM; Ranganathan R; Piñeros M; Znaor A; Mery L; Joko-Fru YW; Dikshit R; Sankaranarayanan R; Swaminathan R; Bray F;
    Lancet Oncol; 2023 Jan; 24(1):22-32. PubMed ID: 36603919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in survival of patients diagnosed with cancer of the digestive organs in the Nordic countries 1964-2003 followed up to the end of 2006.
    Klint A; Engholm G; Storm HH; Tryggvadóttir L; Gislum M; Hakulinen T; Bray F
    Acta Oncol; 2010 Jun; 49(5):578-607. PubMed ID: 20491524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating the impact of treatment and imaging modalities on 5-year net survival of 11 cancers in 200 countries: a simulation-based analysis.
    Ward ZJ; Scott AM; Hricak H; Abdel-Wahab M; Paez D; Lette MM; Vargas HA; Kingham TP; Atun R
    Lancet Oncol; 2020 Aug; 21(8):1077-1088. PubMed ID: 32758462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer survival in sub-Saharan Africa (SURVCAN-3): a population-based study.
    Joko-Fru WY; Bardot A; Bukirwa P; Amidou S; N'da G; Woldetsadik E; Chesumbai G; Korir A; Kamaté B; Koon M; Hansen R; Finesse A; Somdyala N; Chokunonga E; Chigonzoh T; Liu B; Kantelhardt EJ; Parkin DM; Soerjomataram I
    Lancet Glob Health; 2024 Jun; 12(6):e947-e959. PubMed ID: 38762297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the morphology of cutaneous melanoma help to explain the international differences in survival? Results from 1 578 482 adults diagnosed during 2000-2014 in 59 countries (CONCORD-3).
    Di Carlo V; Stiller CA; Eisemann N; Bordoni A; Matz M; Curado MP; Daubisse-Marliac L; Valkov M; Bulliard JL; Morrison D; Johnson C; Girardi F; Marcos-Gragera R; Šekerija M; Larønningen S; Sirri E; Coleman MP; Allemani C;
    Br J Dermatol; 2022 Sep; 187(3):364-380. PubMed ID: 35347700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Life tables for world-wide comparison of relative survival for cancer (CONCORD study).
    Baili P; Micheli A; De Angelis R; Weir HK; Francisci S; Santaquilani M; Hakulinen T; Quaresmas M; Coleman MP;
    Tumori; 2008; 94(5):658-68. PubMed ID: 19112937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data.
    Verdecchia A; Francisci S; Brenner H; Gatta G; Micheli A; Mangone L; Kunkler I;
    Lancet Oncol; 2007 Sep; 8(9):784-96. PubMed ID: 17714993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The burden of cancers and their variations across the states of India: the Global Burden of Disease Study 1990-2016.
    India State-Level Disease Burden Initiative Cancer Collaborators
    Lancet Oncol; 2018 Oct; 19(10):1289-1306. PubMed ID: 30219626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Life tables for global surveillance of cancer survival (the CONCORD programme): data sources and methods.
    Spika D; Bannon F; Bonaventure A; Woods LM; Harewood R; Carreira H; Coleman MP; Allemani C
    BMC Cancer; 2017 Feb; 17(1):159. PubMed ID: 28241815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of patients diagnosed with cancer in the Nordic countries up to 1999-2003 followed to the end of 2006. A critical overview of the results.
    Storm HH; Engholm G; Hakulinen T; Tryggvadóttir L; Klint A; Gislum M; Kejs AM; Bray F
    Acta Oncol; 2010 Jun; 49(5):532-44. PubMed ID: 20491522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 145.